PMID: 698890Jul 1, 1978Paper

Specificity of tumor-associated antibodies in sera of patients with uveal melanoma

Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
S BrownsteinM G Lewis


We have identified antibodies against cytoplasmic components of allogeneic uveal melanoma cells in the sera of 16 of 31 patients with proven intraocular melanoma. Similar antibodies were found in 27% of controls and in 24% of patients with uveal nevi. The antibodies in these 3 groups of subjects were absorbed by components of uveal and cutaneous melanoma cells but not by those of normal choroidal melanocytes, normal uvea and retinal pigment epithelium, dermal nevus, pigmented skin or fetal cells. We found that specificity of the antibodies was also demonstrated by absence of reactivity with normal choroidal melanocytes, loss of reactivity after immune blocking, and absence of reactivity of melanoma antigen with conjugated antihuman immunoglobulin alone. Attempted absorption of the conjugated antihuman immunoglobulin by components of uveal melanoma cells did not alter the reactivity of the conjugated antihuman immunoglobulin.

Related Concepts

Antibody Specificity
Choroid Neoplasms
Cross Reactions
Malignant Tumor of Eye
Melanocytic Nevus
Malignant Neoplasm of Skin

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Related Papers

Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
S BrownsteinM G Lewis
Proceedings of the National Academy of Sciences of the United States of America
A C MorganR A Reisfeld
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Carolina Belmar-LopezPilar Martin-Duque
© 2021 Meta ULC. All rights reserved